Navigation Links
Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Date:12/12/2008

s MammaPrint signature are sensitive to chemotherapy.

About MammaPrint(R)

MammaPrint is the first 'in vitro diagnostic multivariate index assay' (IVDMIA) cleared by the U.S. Food and Drug Administration (FDA). FDA clearance requires clinical and analytical validation and reporting systems to ensure patient safety issues are addressed. Highly accurate, MammaPrint identifies patients with early metastasis - those patients who are likely to develop metastases within five years following surgery. Several authoritative studies have shown that chemotherapy particularly reduces early metastasis risk. In planning treatment, the MammaPrint test result provides a doctor with a clear rationale to assess the benefit of adjuvant chemotherapy in addition to other clinical information and pathology tests.

All MammaPrint tests are conducted in Agendia's CLIA-certified service laboratory. All other breast cancer recurrence assays currently marketed have not been subject to the rigorous FDA clearance process.

About Agendia

Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatments within reach of patients. Building on a cutting edge genomics platform for tumor gene expression profiling, the company's tests aim to help physicians more accurately tailor cancer treatments. The company markets four products, with several new genomic tests under development. In addition, Agendia collaborates with pharmaceutical companies to develop highly effective personalized drugs in the area of oncology. Agendia is based in Huntington Beach, California, and in Amsterdam, The Netherlands. For more information please visit http://www.agendia.com.


'/>"/>
SOURCE Agendia BV
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Agendias MammaPrint(R) Included in 2008 Dutch Institute for Healthcare Improvement CBO Guidelines
2. DNA Test Predicts Harmful Effects of Cancer Drug
3. Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
4. Simple Test Accurately Predicts Risk of Serious Jaundice in Newborns
5. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
6. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
7. Directors Forum: PEPFAR and the Global AIDS Response
8. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
9. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
10. Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response
11. Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015 ... 2015" therapeutic market research report of 68 pages ... online business intelligence library. The report ... on the therapeutic development for Pemphigus , ... assessment by drug target, mechanism of action (MoA), ...
(Date:3/31/2015)... KENNEBUNK, Maine , March 31, 2015 /PRNewswire/ ... aggregated enrollment in Medicare Advantage (MA) plans in ... approximately 17.3 million people were enrolled in Medicare ... of more than 1.3 million members year-over-year.  54.3 ... the Centers for Medicare and Medicaid Services (CMS), ...
(Date:3/31/2015)... , March 31, 2015  SynCardia Systems, Inc. has ... (IDE) clinical study on the effective use of its ... The FDA approval will ... as 30 heart failure patients. Patients enrolled in this ... as a bridge to a donor heart transplant. ...
Breaking Medicine Technology:Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 3FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 4
(Date:3/31/2015)... April is Parkinson’s disease Awareness Month and the ... Days, 30 Ways to Make a Difference. Visit ... offer a new action each day throughout April to make ... this disease. , Every nine minutes there is ... 5,000 individuals in this country will learn they have Parkinson’s ...
(Date:3/31/2015)... March 31, 2015 Medical Technology Solutions ... Medical Practice Edition 2, allowing them to offer the ... with 24 physicians or less. Dragon Medical Practice Edition ... create quality patient records. , "MTSOA is constantly ... to our clients. Our goal has always been to ...
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 St. ... a growing network of leading healthcare systems, major physician ... patient information for the benefit of patients. The health ... record, that supports well coordinated care throughout the continuum ... has a long tradition of providing services to a ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 An individual’s ... most important ligaments in the leg providing stability, load ... their study at today’s Specialty Day meeting of the ... utilized MRI data to determine the potential for biologic ... currently understood about the healing of meniscus tears when ...
(Date:3/31/2015)... 2015 For bariatric health professionals who ... return on their investment, Rice Lake Weighing Systems ... Medicine 2015, April 8-12 at the Colorado Convention Center ... and medical offices, Rice Lake’s BCA uses the most ... Obesity Medicine 2015 delivers clinical and practical knowledge about ...
Breaking Medicine News(10 mins):Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 2Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 3Health News:Medical Technology Solutions of America Announces Availability of Dragon® Medical Practice Edition 2 for Medical Professionals 2Health News:St. Joseph Medical Center Joins Other Leading Healthcare Systems Participating in Greater Houston Healthconnect 2Health News:New Way to Evaluate Meniscus Tear Outcomes 2Health News:Rice Lake Weighing Systems’ Body Composition Analyzer On Display at Obesity Medicine 2015 2
... 80 NHS Hospital Trusts on Sunday, thankfully no patient ... is in charge of the IT services in NHS ... Midlands were interrupted due to the failure of equipment ... log will be maintained till ,the system is restored. ...
... Canada seem to be on the high, which is a ... the spread of disease//. ,Ignorance is certainly not bliss, ... in Canada has reported an alarming figure of 58000 cases ... run a three times enhanced risk of HIV infection as ...
... the study conducted by Stephen Karpiak, a former research ... that many senior Americans above 50 years living with ... , This study was conducted in New York and1,000 ... Disease Control and Prevention statistics showed that more than ...
... health-care workers don protective clothing to stave-off infection ... diseases//, and bio-terrorism, they are still vulnerable ... Queen's University. ,"The strengths and ... considered when recommendations are made about which choice ...
... three years of age are underweight or malnourished in India, ... and Orissa.// ,Minister of State for Women and Child ... Rajya Sabha Monday that the national average of children below ... 1993 to 47 percent in 1999. ,Quoting the ...
... which is said to prevent about 75 percent of cervical ... women already exposed to the disease causing virus//, according to ... has been approved for women aged 9 to 26. However ... at the University of California-Irvine, argued that with more widespread ...
Cached Medicine News:Health News:Protective Clothing of Health Workers Insufficent Against Contamination 2Health News:Demand for More Widespread Use of HPV Vaccine 2Health News:Demand for More Widespread Use of HPV Vaccine 3
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
Elmed BC 50 M/M is an all purpose bipolar coagulator with a macro and micro mode. In the micro mode, the unit is ideally suitable for wet-field coagulation in ophthalmology, neurosurgery and other mi...
...
...
Medicine Products: